Danaher | DHR - Zahlungsmittel Und Äquivalente

Aktienkurs
180.44
Täglich Wechseln
3.19 1.80%
Monatlich
-1.88%
Jährlich
-7.90%
Q2 Prognose
173.46




Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 8.52B 1.01B 2025-12
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1B 103.43M 2025-09
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 326M 37M 2025-12
Edwards Lifesciences USD 2.4B 538M 2026-03
ESCO Technologies USD 103.82M 2.47M 2025-12
Fortive USD 375.5M 55.3M 2025-12
Henry Schein USD 136M 9M 2025-09
Illumina USD 1.42B 368M 2025-12
Intuitive Surgical USD 7.98B 1.05B 2026-03
IQVIA Holdings USD 1.98B 166M 2025-12
Keysight Technologies USD 2.18B 305M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Medtronic USD 1.15B 135M 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
OraSure Technologies USD 199.28M 17.2M 2025-12
Quest Diagnostics USD 393M 27M 2026-03
Quidel USD 169.8M 71.7M 2025-12
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Roper Industries USD 297.4M 22.6M 2025-12
Stryker USD 4.01B 755M 2025-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 587.83M 128.71M 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12